Trince
Philip Mathuis has a diverse work experience spanning over several industries and roles. Philip is currently the Co-Founder and CEO of Trince, a spin-off company from Ghent University that focuses on advancing cell-based science and therapeutics. Additionally, they are the Managing Partner of Bacon Invest, a position they have held since 2021.
Prior to these roles, Philip Mathuis was the Owner of Aquaqo Consulting, a consultancy company where they advised start-ups and companies on business strategy, market development, international growth, and M&A. Philip also served as the President of the Board of Directors at Aenitis Technologies.
Philip Mathuis has a background in founding and leading companies. Philip was the Founder and CEO of Ovizio Imaging Systems, a spin-off company of the Free University of Brussels that marketed Digital Holographic Microscopy products and services. Philip also founded and served as the CEO of a2z solutions, a company offering managed ICT solutions.
In their earlier career, Philip Mathuis held executive positions at Versatel and Ascom Ericsson Wireless Systems, where they served as CEO and VP of New Business Development respectively. Philip also held the role of Operations Director at Ascom Ericsson Wireless Systems France.
Furthermore, Philip Mathuis has experience in board membership and advisory roles. Philip was a Director at AMAB, a sheltered workplace, and served on the advisory board of Qbus NV, a smart home leader. Philip has also provided advisory services to companies such as Stylelabs NV and Sumum BV.
Overall, Philip Mathuis has demonstrated expertise in various areas including entrepreneurship, leadership, strategy, and business development across multiple industries.
Philip Mathuis attended ESCP Business School from 1996 to 1997, where they obtained their MBA degree. Additionally, they also attended the MIT Sloan School of Management, although the specific dates and degree obtained from this institution are not provided.
This person is not in any teams
This person is not in any offices
Trince
Trince is a spin-off company from Ghent University dedicated to advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo. The company's LumiPore transfection platform, which is covered by a portfolio of pending patents, combines laser exposure with photothermal nanoparticles to convert light energy into heat to transiently permeabilize the cellular plasma membrane. It can be used to deliver a wide variety of effector molecules (e.g. nucleic acids or proteins) into virtually any cell type, including hard-to-transfect cells such as immune cells for cell therapies. The technology not only makes it easier to bring genetic material into cells in high-throughput. It also ensures that this is done in a gentle manner, maximizing the therapeutic quality of the final cell product. www.trincebio.com